Volume 107, Issue 3 pp. 548-554

Anomalies of the CD8+ T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8+CD28 T cells

F. A. AROSA

F. A. AROSA

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
L. OLIVEIRA

L. OLIVEIRA

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
G. PORTO

G. PORTO

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Department of Haematology, Santo Antonio General Hospital, Porto, Portugal

Search for more papers by this author
B. M. DA SILVA

B. M. DA SILVA

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
W. KRUIJER

W. KRUIJER

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
J. VELTMAN

J. VELTMAN

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
M. DE SOUSA

M. DE SOUSA

Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, University of Porto

Search for more papers by this author
First published: 29 October 2003
Citations: 63
Fernando A. Arosa Department of Molecular Immunology and Pathology, Abel Salazar Institute for the Biomedical Sciences, Largo do Prof. Abel Salazar, 2. 4050 Porto, Portugal.

Abstract

The present study consists of a phenotypic and functional characterization of peripheral blood T lymphocytes in a group of 21 patients with hereditary haemochromatosis (HH), an MHC class I-linked genetic disease resulting in iron overload, and a group of 30 healthy individuals, both HLA-phenotyped. The HH patients studied showed an increased percentage of CD8+ CD28 T cells with a corresponding reduction in the percentage of CD8+ CD28+ T cells in peripheral blood relative to healthy blood donors. No anomalies of CD28 expression were found in the CD4+ subset. The presence of the HLA-A3 antigen but not age accounted for these imbalances. Thus, an apparent failure of the CD8+ CD28+ T cell population ‘to expand’, coinciding with an ‘expansion’ of CD8+ CD28 T cells in peripheral blood of HLA-A3+ but not HLA-A3 HH patients was observed when compared with the respective HLA-A3-matched control group. A significantly higher percentage of HLA-DR+ but not CD45RO+ cells was also found within the peripheral CD8+ T cell subset in HH patients relative to controls. Phytohaemagglutinin (PHA) stimulation of peripheral blood mononuclear cells (PBMC) for 5 days showed: (i) that CD8+ CD28+ T cells both in controls and HH were able to expand in vitro; (ii) that CD8+ CD28 T cells decreased markedly after activation in controls but not in HH patients. Moreover, functional studies showed that CD8+ cytotoxic T lymphocytes (CTL) from HH patients exhibited a diminished cytotoxic activity (approx. two-fold) in standard 51Cr-release assays when compared with CD8+ CTL from healthy controls. The present results provide additional evidence for the existence of phenotypic and functional anomalies of the peripheral CD8+ T cell pool that may underlie the clinical heterogeneity of this iron overload disease. They are of particular relevance given the recent discovery of a novel mutated MHC class I-like gene in HH.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.